Review of 31 cases of morphologic hepatitis in liver transplant patients not related to disease recurrence

R. E. Nakhleh, M. Krishna, A. P. Keaveny, Rolland Dickson, B. Rosser, Justin H Nguyen, J. L. Steers

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Aims. We examined the clinical and pathologic features of morphologic hepatitis occurring after liver transplantation (LT) that is unrelated to disease recurrence. Methods. Between February 1998 and December 2003, 704 primary LTs were performed at our center. Patients transplanted for diagnoses with low risk of disease recurrence were considered for our study (n = 282). Those with hepatitis C (HCV), hepatitis B (HBV), primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and autoimmune hepatitis (AIH) were excluded. Those with morphologic hepatitis comprised our case series and had medical records reviewed for clinical associations, duration, and outcome. Results. Thirty-one cases were identified. They were transplanted for cryptogenic cirrhosis (n = 13), steatohepatitis (n = 12), alpha-1-antitrypsin deficiency (n = 3), tumor (n = 2), and acetaminophen toxicity (n = 1); 22 cases (67%) presented within the first 8 months post-LT (range, 0.5-72 months). Histological activity was mild in 19 and moderate in 12. Associated conditions were identified in 19 patients (57%) with 3 categories being identified: probable drug toxicity (n = 7), systemic infection (n = 4), and mechanical or hemodynamic abnormalities (n = 8). Of the 25 cases that underwent follow-up biopsy 2 to 32 months (mean, 15.5 months) after the index biopsy, 10 cases had resolution and 15 cases had persistence of the infiltrate. One patient had evidence of de novo HBV infection. Conclusions. Morphologic hepatitis occurred in 11% of patients at low risk for disease recurrence. Associated conditions could be grouped into three categories: drug toxicity, systemic infection, and mechanical or hemodynamic factors. Most cases did not appear to progress or improved over time, with no allograft loss occurring as a result of chronic hepatitis.

Original languageEnglish (US)
Pages (from-to)1240-1242
Number of pages3
JournalTransplantation Proceedings
Volume37
Issue number2
DOIs
StatePublished - Mar 2005

Fingerprint

Hepatitis
Transplants
Recurrence
Liver
Drug-Related Side Effects and Adverse Reactions
Liver Transplantation
Infection
Hemodynamics
alpha 1-Antitrypsin Deficiency
Biopsy
Autoimmune Hepatitis
Sclerosing Cholangitis
Biliary Liver Cirrhosis
Fatty Liver
Chronic Hepatitis
Acetaminophen
Hepatitis C
Hepatitis B
Medical Records
Allografts

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Review of 31 cases of morphologic hepatitis in liver transplant patients not related to disease recurrence. / Nakhleh, R. E.; Krishna, M.; Keaveny, A. P.; Dickson, Rolland; Rosser, B.; Nguyen, Justin H; Steers, J. L.

In: Transplantation Proceedings, Vol. 37, No. 2, 03.2005, p. 1240-1242.

Research output: Contribution to journalArticle

Nakhleh, R. E. ; Krishna, M. ; Keaveny, A. P. ; Dickson, Rolland ; Rosser, B. ; Nguyen, Justin H ; Steers, J. L. / Review of 31 cases of morphologic hepatitis in liver transplant patients not related to disease recurrence. In: Transplantation Proceedings. 2005 ; Vol. 37, No. 2. pp. 1240-1242.
@article{8fde9c116cdd4156a50ff2709f0b3947,
title = "Review of 31 cases of morphologic hepatitis in liver transplant patients not related to disease recurrence",
abstract = "Aims. We examined the clinical and pathologic features of morphologic hepatitis occurring after liver transplantation (LT) that is unrelated to disease recurrence. Methods. Between February 1998 and December 2003, 704 primary LTs were performed at our center. Patients transplanted for diagnoses with low risk of disease recurrence were considered for our study (n = 282). Those with hepatitis C (HCV), hepatitis B (HBV), primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and autoimmune hepatitis (AIH) were excluded. Those with morphologic hepatitis comprised our case series and had medical records reviewed for clinical associations, duration, and outcome. Results. Thirty-one cases were identified. They were transplanted for cryptogenic cirrhosis (n = 13), steatohepatitis (n = 12), alpha-1-antitrypsin deficiency (n = 3), tumor (n = 2), and acetaminophen toxicity (n = 1); 22 cases (67{\%}) presented within the first 8 months post-LT (range, 0.5-72 months). Histological activity was mild in 19 and moderate in 12. Associated conditions were identified in 19 patients (57{\%}) with 3 categories being identified: probable drug toxicity (n = 7), systemic infection (n = 4), and mechanical or hemodynamic abnormalities (n = 8). Of the 25 cases that underwent follow-up biopsy 2 to 32 months (mean, 15.5 months) after the index biopsy, 10 cases had resolution and 15 cases had persistence of the infiltrate. One patient had evidence of de novo HBV infection. Conclusions. Morphologic hepatitis occurred in 11{\%} of patients at low risk for disease recurrence. Associated conditions could be grouped into three categories: drug toxicity, systemic infection, and mechanical or hemodynamic factors. Most cases did not appear to progress or improved over time, with no allograft loss occurring as a result of chronic hepatitis.",
author = "Nakhleh, {R. E.} and M. Krishna and Keaveny, {A. P.} and Rolland Dickson and B. Rosser and Nguyen, {Justin H} and Steers, {J. L.}",
year = "2005",
month = "3",
doi = "10.1016/j.transproceed.2004.12.113",
language = "English (US)",
volume = "37",
pages = "1240--1242",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Review of 31 cases of morphologic hepatitis in liver transplant patients not related to disease recurrence

AU - Nakhleh, R. E.

AU - Krishna, M.

AU - Keaveny, A. P.

AU - Dickson, Rolland

AU - Rosser, B.

AU - Nguyen, Justin H

AU - Steers, J. L.

PY - 2005/3

Y1 - 2005/3

N2 - Aims. We examined the clinical and pathologic features of morphologic hepatitis occurring after liver transplantation (LT) that is unrelated to disease recurrence. Methods. Between February 1998 and December 2003, 704 primary LTs were performed at our center. Patients transplanted for diagnoses with low risk of disease recurrence were considered for our study (n = 282). Those with hepatitis C (HCV), hepatitis B (HBV), primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and autoimmune hepatitis (AIH) were excluded. Those with morphologic hepatitis comprised our case series and had medical records reviewed for clinical associations, duration, and outcome. Results. Thirty-one cases were identified. They were transplanted for cryptogenic cirrhosis (n = 13), steatohepatitis (n = 12), alpha-1-antitrypsin deficiency (n = 3), tumor (n = 2), and acetaminophen toxicity (n = 1); 22 cases (67%) presented within the first 8 months post-LT (range, 0.5-72 months). Histological activity was mild in 19 and moderate in 12. Associated conditions were identified in 19 patients (57%) with 3 categories being identified: probable drug toxicity (n = 7), systemic infection (n = 4), and mechanical or hemodynamic abnormalities (n = 8). Of the 25 cases that underwent follow-up biopsy 2 to 32 months (mean, 15.5 months) after the index biopsy, 10 cases had resolution and 15 cases had persistence of the infiltrate. One patient had evidence of de novo HBV infection. Conclusions. Morphologic hepatitis occurred in 11% of patients at low risk for disease recurrence. Associated conditions could be grouped into three categories: drug toxicity, systemic infection, and mechanical or hemodynamic factors. Most cases did not appear to progress or improved over time, with no allograft loss occurring as a result of chronic hepatitis.

AB - Aims. We examined the clinical and pathologic features of morphologic hepatitis occurring after liver transplantation (LT) that is unrelated to disease recurrence. Methods. Between February 1998 and December 2003, 704 primary LTs were performed at our center. Patients transplanted for diagnoses with low risk of disease recurrence were considered for our study (n = 282). Those with hepatitis C (HCV), hepatitis B (HBV), primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and autoimmune hepatitis (AIH) were excluded. Those with morphologic hepatitis comprised our case series and had medical records reviewed for clinical associations, duration, and outcome. Results. Thirty-one cases were identified. They were transplanted for cryptogenic cirrhosis (n = 13), steatohepatitis (n = 12), alpha-1-antitrypsin deficiency (n = 3), tumor (n = 2), and acetaminophen toxicity (n = 1); 22 cases (67%) presented within the first 8 months post-LT (range, 0.5-72 months). Histological activity was mild in 19 and moderate in 12. Associated conditions were identified in 19 patients (57%) with 3 categories being identified: probable drug toxicity (n = 7), systemic infection (n = 4), and mechanical or hemodynamic abnormalities (n = 8). Of the 25 cases that underwent follow-up biopsy 2 to 32 months (mean, 15.5 months) after the index biopsy, 10 cases had resolution and 15 cases had persistence of the infiltrate. One patient had evidence of de novo HBV infection. Conclusions. Morphologic hepatitis occurred in 11% of patients at low risk for disease recurrence. Associated conditions could be grouped into three categories: drug toxicity, systemic infection, and mechanical or hemodynamic factors. Most cases did not appear to progress or improved over time, with no allograft loss occurring as a result of chronic hepatitis.

UR - http://www.scopus.com/inward/record.url?scp=17844407928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17844407928&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2004.12.113

DO - 10.1016/j.transproceed.2004.12.113

M3 - Article

C2 - 15848682

AN - SCOPUS:17844407928

VL - 37

SP - 1240

EP - 1242

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 2

ER -